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as dr. Juan Pablo Zabala’s excellent article 
(1) demonstrates, Chagas disease offers a clear ex-
ample of the need to find points of connection be-
tween the biomedical and social sciences, which 
often travel in separate lanes. the complexity of 
this endemic disease requires the perspectives of 
different disciplines as well as the making of po-
litical decisions to which these different disciplines 
should contribute. In this way, social, bioethical, 
psychological, anthropological and philosophical 
aspects must be present in any discussion aimed 
at making the problem “visible” and contributing 
to its solution, considering the human being as 
the main objective. Foucalt’s (2) concepts of bio-
politics and biopower and badiou’s (3) notion of 
spectacle bodies, enslaved bodies and bodies with 
ideas serve as examples of this.    
I will discuss some aspects that I consider 
significant (although strictly speaking, Zabala’s 
whole article is significant) from a biomedical 
perspective based in my professional training and 
from a social perspective based in my personal 
inclinations. 
I agree with Zabala’s lucid way of addressing 
the problem using the tension of visibility-invis-
ibility. I also consider central his questioning of 
the persistence of the disease for more than 100 
years and his critique of the simplistic approaches 
adopted in an attempt to explain that persistence.
the multiple paradoxes accompanying 
Chagas disease start with the discovery of 
Trypanosoma cruzi, the etiological agent, and the 
disease caused by this parasite. due to several cir-
cumstances – among them the famous “mistake of 
Carlos Chagas” in attempting to establish a cause-
and-effect relationship between trypanosomiasis 
and goiter, two entities associated in time and 
space – this disease has always been the subject 
of discussion. Unfortunately, these discussions, 
rather than contributing to the solution of the 
problem, have pushed it into the background and 
subordinated it to irreconcilable personal posi-
tions, political ups and downs, excessive “medical-
ization,” among other situations that have favored 
such descriptions as “forgotten disease,” “silent 
and silenced endemic disease” or “hidden harm.” 
even the World Health Organization (WHO) in-
cludes it among the sadly labeled “neglected dis-
eases,” an adjective undoubtedly well applied to 
describe men and women whose “invisibility” 
marginalizes them (1), as stated by Zabala. Or, in 
the words of dr. Ramón Carrillo: “Faced with the 
diseases caused by misery, faced with the people’s 
sorrow, anguish and social misfortune, microbes, 
as causes of disease, are poor causes.” 
In the article under discussion, there is a 
quote from a WHO publication (4) according to 
which “official data” reveal that 8 million people 
are infected. If in Latin america just a few years 
ago the number of infected was estimated at 18 
million people, it is difficult to understand how 
this last official data, “decreasing” year by year, 
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were reached. Was it due to errors in previous 
estimates? to the exaggerated “optimism” of of-
ficial data? To the tendency to make the problem 
less “visible”? a disparity of 10 million people 
between these estimates is too high to permit a 
rational explanation of the disease’s “statistical 
disappearance.” Indeed, as Chagas disease is an 
indicator of poor quality of life, some governments 
of the endemic countries may be tempted to favor 
the “invisibility” mentioned by dr. Zabala, in ad-
dition to the neglect of people who live in hyper-
endemic areas, such as the wichis, pilagás and 
other ethnic groups from the geographical region 
of Gran Chaco. In a wichi community, a few years 
ago, we detected a prevalence of infection 10 
times higher than the national average (5) – and 
unfortunately, taking Carrillo’s quote into account, 
Chagas disease may not the main problem of these 
communities.        
What other factors may be influencing this 
invisibility? Undoubtedly, university education 
is another important factor. In this regard, at the 
training Sessions to Reinforce Chagas disease 
education in Health Sciences degree Programs 
(6), held at the Universidad Nacional de Córdoba 
and attended by professors of Health Sciences 
from all over the country, the issues raised were 
the existing deficiencies in education and the 
pressing need to reinforce the teaching of Chagas 
disease and other diseases of regional impact. It 
was discussed that the focus should be placed 
on undergraduate degree programs, given that if 
students do not perceive the importance of the 
problem during their undergraduate training, 
their interest will be limited during graduate in-
struction, for reasons also explained by dr. Zabala 
(1). these Sessions, which have been held three 
times in Córdoba since 2008 and, thanks to the 
support of the Pan american Health Organization 
(PaHO), also took place in Recife and Lima in 
2009 and 2010, seek as a primary objective 
to denaturalize the idea that the diagnosis and 
treatment of Chagas disease only concerns “spe-
cialists in Chagas disease.” Instead, they propose 
that physicians of any specialty should be familiar 
with the basic concepts necessary for prevention, 
diagnosis and treatment; that biochemists should 
have the basic skills and knowledge to carry out 
and interpret parasitological and serological diag-
noses; and so on in all of the health-related degree 
programs. One effect of these Sessions was that 
they served as the base for the National Chagas 
Program to include for the first time education, in 
addition to information and communication, as a 
tool for controlling the endemic disease (7).     
In this vein, dr. Zabala’s article presents a 
topic offering an interesting motive for debate: 
Should cardiac diseases be treated by “Chagas 
specialists”? From our standpoint, based on the 
conclusions of the Sessions mentioned previously, 
pediatricians, neonatologists and infectologists 
should be trained to treat all infections, including 
acute, vectorial and congenital infections, and, 
similarly, clinicians, cardiologists or gastroen-
terologists should be able to provide medical or 
surgical treatment of chronic Chagas disease. to 
the contrary, the treatment of individuals infected 
with Chagas, prevention in the case of pregnant 
women or at-risk populations, prophylaxis and im-
munosuppressive treatment, to name certain con-
crete examples, is unfeasible.   
As to the influence exerted by the scien-
tific research into Chagas disease, the following 
statement opens a debate that greatly exceeds the 
possibilities of this commentary: “the scant con-
crete incidence of science in people’s living condi-
tions” (1 p. 11). I agree that research has frequently 
dealt with the Trypanosoma cruzi-host interaction 
as an interesting experimental model rather than 
to contribute to solving concrete problems, partly 
distorting the objectives of the national pro-
grams promoting Chagas disease research, which 
reached their peak in the 1970s and 1980s. It is to 
me beyond question that without basic research, 
advances in knowledge are unthinkable; indeed, 
that there are abundant examples of important 
medical applications which were the product 
of “basic research.” Nevertheless, in the case of 
Chagas disease, there has perhaps thus far been 
less applicability to the health field than would be 
expected. 
It is however fair to mention, as does dr. 
Zabala’s article, the numerous research studies 
into clinical medicine, epidemiology, vectors, 
reservoirs and many other aspects which led to 
“the rediscovery of Chagas disease” by the team 
headed by Salvador Mazza in the argentine 
Regional Pathology Study Mission [Misión de 
Estudios de Patología Regional Argentina]. In my 
view, this was one of the most important periods 
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in the history of argentine medicine, in which 
physicians in cities and towns of numerous prov-
inces took up Mazza’s call to study an unknown 
and controversial disease, apparently restricted to 
tropical regions but nonetheless found in prov-
inces such as Mendoza and Neuquén, to name 
only the southernmost provinces (8-10). Simply 
amazing.    
Since the 1960s there have also been many 
significant research findings regarding the clinical 
profile of the disease (11,12) and congenital trans-
mission (13,14), among other aspects; such trans-
mission has been responsible to a great extent for 
the urbanization and globalization of Chagas in-
fection. also important to mention are the notable 
advances in serological diagnosis and, possibly in 
the future, molecular biology methods still in the 
standardization stage (15), in addition to the dem-
onstration of the efficacy of a vaccine for domestic 
animals – identified reservoirs of the disease – 
which could interrupt the epidemiological chain 
in active transmission sites (16,17). there are 
certainly more examples that the limited space of 
this commentary impedes me from mentioning, 
however I would like to reiterate that scientific 
research should show greater commitment to the 
practical applications of its studies.  
In terms of the “visibility-invisibility” tension, 
heated controversies still exist regarding the fol-
lowing aspect addressed in the article: the “random 
barrier separating the infected from the ill” (1 
p.13). Interesting questions about the chronic 
stage are raised: Who are only “infected”? Who 
are “sick”? does it depend on the sensitivity of the 
study methods? does it depend on the opinions of 
experts that may vary from one generation to the 
next? technological advances undoubtedly fuel 
this controversy, which is not exclusive to Chagas. 
the concept of “proto-diseases” is surrounded by 
controversies connected to the pharmaceutical 
companies’ interests.   
the apparent paradigm by which 25% to 
30% of infected individuals develop cardiac or di-
gestive pathologies decades after infection is cur-
rently under discussion, to such an extent that the 
argentine Federation of Cardiology [Federación 
Argentina de Cardiología] has recommended 
changing the denomination “undetermined 
stage” to “chronic stage without demonstrable 
pathology.” this is a matter of debate which, of 
course, includes the question of what patients 
should be treated with antiparasitic drugs. For 
years infectologists and cardiologists have strongly 
disagreed with each other, and it seems that in the 
present the debate has been rekindled.   
to conclude, I would like to make reference 
to one of Zabala’s reflections, in which the author 
states that the persistence of Chagas disease may 
be “the predictable and logical result of the actions 
of the different social actors involved” (1 p.18). 
Such a statement poses a formidable challenge 
to government officials, politicians, researchers, 
professors, health care professionals, and other 
“social actors.” Perhaps the problem is not 
“Chagas disease,” but rather the infected, sick or 
at-risk individuals, primarily children, who hope 
to “make themselves visible” while immersed in 
living conditions that contribute to the persistence 
of endemic diseases and the emergence or reemer-
gence of diseases we though had been eradicated.
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the diversity of the commentaries made put 
into evidence some of the tensions mentioned 
throughout my article, enabling us to observe the 
concrete expression of the paradoxes. the com-
mentators, not only experts in Chagas disease but 
also actors involved in day-to-day interventions, 
give examples of the implications and limitations 
they face every day in the control of the disease. 
In this sense, and returning to the question of 
how to explain the persistence of the disease over 
100 years after its discovery, there seems to be 
consensus around the idea that the primary cause 
is the lack of actions sustained over time. With 
slight differences, most commentators hold that 
Chagas disease control is a matter that depends on 
political willingness to allocate funds for control 
strategies that have already been applied in the 
last decades. “Much has been done,” says Freilij (1 
p.29), “but there is still much more to do.” and the 
indicators described serve to support this position.
